• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血嗜酸性粒细胞计数可预测 COPD 加重的住院时间。

Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.

机构信息

SH Ho Research Center in Respiratory Diseases, Division of Respiratory Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

出版信息

Respirology. 2020 Mar;25(3):259-266. doi: 10.1111/resp.13660. Epub 2019 Aug 6.

DOI:10.1111/resp.13660
PMID:31385389
Abstract

BACKGROUND AND OBJECTIVE

Airway inflammation accompanying exacerbations varies among individuals with some having neutrophilic, while others showing eosinophilic inflammation. This study assessed the cut-off values of blood eosinophil count for identifying subjects with longer hospital length of stay (LOS) with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

METHODS

Patients were recruited at presentation to the hospital with an AECOPD. Complete blood picture with differential count was taken on admission. Patients were treated with a standard course of systemic corticosteroid and antibiotic and evaluated at 8 weeks post-exacerbation for lung function measurement and 6-min walk. They were followed up in 1 year for any readmissions or mortality. Cut-off values of eosinophils for assessment of longer LOS were calculated using receiver operating characteristic (ROC) curve analysis.

RESULTS

A total of 346 patients with admission eosinophil count were included in the analysis (333 (96.2%) were males; mean ± SD age: 74.9 ± 7.8 years; mean forced expiratory volume in 1 s (FEV ): 43.4 ± 16.3% predicted). The median (interquartile range (IQR)) of the absolute peripheral eosinophil count, percent eosinophil count and LOS were 0.11 (0.25) × 10 /L, 1 (3) % and 5 (7) days, respectively. Using the median LOS of ≥5 days as the cut-off, ROC analysis of the cut-off value of eosinophil count associated with longer LOS was at <2% (area under the curve (AUC): 0.666, P < 0.001) while absolute eosinophil count was at <0.144 × 10 /L (AUC: 0.645, P < 0.001). These eosinophil cut-off values could predict longer LOS independent of age, lung function and previous hospital admissions, but had no association with readmissions for AECOPD and mortality at 12 months.

CONCLUSION

An eosinophil value of <0.144 × 10 /L on admission or <2% was associated with longer hospital LOS for AECOPD.

摘要

背景与目的

伴有加重的气道炎症在个体之间存在差异,有些表现为中性粒细胞炎症,而另一些则表现为嗜酸性粒细胞炎症。本研究评估了血嗜酸性粒细胞计数的截断值,以确定慢性阻塞性肺疾病(COPD)急性加重(AECOPD)患者的住院时间(LOS)较长。

方法

在 AECOPD 住院时招募患者。入院时进行全血细胞计数和分类计数。患者接受标准疗程的全身皮质类固醇和抗生素治疗,并在 AECOPD 后 8 周进行肺功能测量和 6 分钟步行评估。在 1 年内对任何再入院或死亡进行随访。使用接受者操作特征(ROC)曲线分析计算嗜酸性粒细胞截断值,以评估较长 LOS。

结果

共纳入 346 例入院时嗜酸性粒细胞计数患者进行分析(333 例(96.2%)为男性;平均年龄(标准差):74.9±7.8 岁;平均用力呼气量(FEV1):43.4±16.3%预测值)。绝对外周血嗜酸性粒细胞计数、嗜酸性粒细胞百分比和 LOS 的中位数(四分位间距(IQR))分别为 0.11(0.25)×109/L、1(3)%和 5(7)天。使用中位 LOS≥5 天作为截断值,嗜酸性粒细胞计数与较长 LOS 相关的截断值的 ROC 分析结果为<2%(曲线下面积(AUC):0.666,P<0.001),而绝对嗜酸性粒细胞计数为<0.144×109/L(AUC:0.645,P<0.001)。这些嗜酸性粒细胞截断值可独立于年龄、肺功能和既往住院情况预测较长的 LOS,但与 12 个月时 AECOPD 的再入院和死亡率无关。

结论

入院时嗜酸性粒细胞值<0.144×109/L 或<2%与 AECOPD 的住院时间较长有关。

相似文献

1
Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.血嗜酸性粒细胞计数可预测 COPD 加重的住院时间。
Respirology. 2020 Mar;25(3):259-266. doi: 10.1111/resp.13660. Epub 2019 Aug 6.
2
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.稳定期 COPD 中嗜酸性粒细胞恶化与嗜酸性粒细胞水平的关系。
BMC Pulm Med. 2021 Mar 2;21(1):74. doi: 10.1186/s12890-021-01443-4.
3
High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.高嗜酸性粒细胞计数与 COPD 加重患者的住院时间缩短相关 - 一项回顾性分析。
Respir Res. 2020 May 6;21(1):106. doi: 10.1186/s12931-020-01365-5.
4
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
5
The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD.急诊科有气道疾病的急性喘息成人:COPD 加重的回顾性病历回顾。
Int J Chron Obstruct Pulmon Dis. 2019 May 7;14:971-977. doi: 10.2147/COPD.S190085. eCollection 2019.
6
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.血液嗜酸性粒细胞与 COPD 严重住院加重期的结局。
Chest. 2016 Aug;150(2):320-8. doi: 10.1016/j.chest.2016.01.026. Epub 2016 Feb 3.
7
Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.COPD 加重期的嗜酸性粒细胞与住院次数增加有关。
Chest. 2017 Feb;151(2):366-373. doi: 10.1016/j.chest.2016.10.003. Epub 2016 Oct 13.
8
Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.非哮喘-慢性阻塞性肺疾病(COPD)重叠综合征患者血液嗜酸性粒细胞计数的临床意义。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464. doi: 10.2147/COPD.S129321. eCollection 2017.
9
Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.慢性阻塞性肺疾病首次住院时的嗜酸性粒细胞计数:医疗服务利用情况比较
Int J Chron Obstruct Pulmon Dis. 2018 Oct 1;13:3045-3054. doi: 10.2147/COPD.S170743. eCollection 2018.
10
Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.COPD 后续严重加重期嗜酸粒细胞分类的稳定性。
BMJ Open Respir Res. 2021 Aug;8(1). doi: 10.1136/bmjresp-2021-000960.

引用本文的文献

1
Blood Eosinophil Stability Predicts Clinical Outcomes in Hospitalized Patients with Acute Exacerbations of COPD.血液嗜酸性粒细胞稳定性可预测慢性阻塞性肺疾病急性加重期住院患者的临床结局。
Int J Chron Obstruct Pulmon Dis. 2025 Aug 22;20:2913-2923. doi: 10.2147/COPD.S536911. eCollection 2025.
2
Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort Study.入院嗜酸性粒细胞计数与慢性阻塞性肺疾病(COPD)老年患者2019冠状病毒病(COVID-19)预后的关系:一项全地区队列研究。
Clin Respir J. 2025 Apr;19(4):e70070. doi: 10.1111/crj.70070.
3
Differences in Blood Eosinophil Level During Stable Disease and During Exacerbation of COPD and Exacerbation Risks.
慢性阻塞性肺疾病稳定期与急性加重期的血嗜酸性粒细胞水平差异及急性加重风险
Lung. 2025 Feb 27;203(1):37. doi: 10.1007/s00408-025-00792-9.
4
Factors Affecting the Length of Hospital Stay in Hypercapnic Respiratory Failure.影响高碳酸血症呼吸衰竭住院时间的因素
Diagnostics (Basel). 2024 Dec 25;15(1):14. doi: 10.3390/diagnostics15010014.
5
Eosinophil count and clinical outcome in patients with acute exacerbation of Chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者的嗜酸性粒细胞计数与临床结局
J Prev Med Hyg. 2024 Oct 31;65(3):E389-E394. doi: 10.15167/2421-4248/jpmh2024.65.3.3267. eCollection 2024 Sep.
6
Association of blood eosinophils with corticosteroid treatment failure stratified by smoking status among inpatients with AECOPD.吸烟状况分层的 AECOPD 住院患者中血嗜酸性粒细胞与皮质类固醇治疗失败的相关性。
BMJ Open Respir Res. 2024 Apr 12;11(1):e001634. doi: 10.1136/bmjresp-2023-001634.
7
Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和嗜酸性粒细胞与淋巴细胞比值(ELR)作为慢性阻塞性肺疾病急性加重(AECOPD)患者的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:501-518. doi: 10.2147/COPD.S447519. eCollection 2024.
8
Blood Eosinophil Count and Its Determinants in a Chinese Population-Based Cohort.基于人群的中国队列研究中血嗜酸性粒细胞计数及其影响因素。
Respiration. 2024;103(2):70-78. doi: 10.1159/000535989. Epub 2024 Jan 22.
9
Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.慢性阻塞性肺疾病(COPD)患者再入院的预测因素——一项系统综述
Int J Chron Obstruct Pulmon Dis. 2023 Nov 18;18:2581-2617. doi: 10.2147/COPD.S418295. eCollection 2023.
10
The Prognostic Value of Blood Eosinophil Level in AECOPD is Influenced by Corticosteroid Treatment During Hospitalization.慢性阻塞性肺疾病急性加重期(AECOPD)患者血液嗜酸性粒细胞水平的预后价值受住院期间糖皮质激素治疗的影响。
J Inflamm Res. 2023 Aug 2;16:3233-3243. doi: 10.2147/JIR.S421605. eCollection 2023.